Impact of the Extended Thrombolysis Time Window on the Proportion of Recombinant Tissue-Type Plasminogen Activator-Treated Stroke Patients and on Door-to-Needle Time

Trends in thrombolytic use for ischemic stroke in the United States

(2010) Margaret C. Fang et al.   Journal of Hospital Medicine

Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR

(2010) Niaz Ahmed et al.   LANCET NEUROLOGY

Dissemination of Thrombolysis for Acute Ischemic Stroke Across a Nation

(2010) Marie Eriksson et al.   STROKE

The “Golden Hour” and Acute Brain Ischemia

(2010) Jeffrey L. Saver et al.   STROKE

Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke

(2009) S. K. Kim et al.   EUROPEAN JOURNAL OF NEUROLOGY

Paper of the year 2008: results

(2009) William Summerskill   LANCET

US Geographic Distribution of rt-PA Utilization by Hospital for Acute Ischemic Stroke

(2009) Dawn Kleindorfer et al.   STROKE

Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale

(2009) Maarten G. Lansberg et al.   STROKE

Hospital Rates of Thrombolysis for Acute Ischemic Stroke

(2009) Jeroen D.H. van Wijngaarden et al.   STROKE

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE

National US Estimates of Recombinant Tissue Plasminogen Activator Use

(2008) Dawn Kleindorfer et al.   STROKE